Hing Wong C.'s most recent trade in HCW Biologics Inc was a trade of 8,054 Common Stock done at an average price of $7.4 . Disclosure was reported to the exchange on May 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.45 per share. | 16 May 2025 | 8,054 | 501,911 | - | 7.4 | 60,002 | Common Stock |
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 26.00 per share. | 07 May 2025 | 92,500 | 493,857 | - | 26 | 2,405,000 | Common Stock |
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 May 2025 | 46,250 | 46,250 | - | - | Common Stock Purchase Warrant | |
| HCW Biologics Inc | Hing Wong C. | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.40 per share. | 20 Feb 2024 | 739,288 | 16,054,156 | - | 1.4 | 1,035,003 | Common Stock |
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.55 per share. | 30 May 2023 | 3,000 | 15,309,468 | - | 1.6 | 4,658 | Common Stock |
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.55 per share. | 30 May 2023 | 2,000 | 15,311,468 | - | 1.5 | 3,092 | Common Stock |
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.70 per share. | 08 Sep 2022 | 6,000 | 15,306,468 | - | 2.7 | 16,200 | Common Stock |
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.67 per share. | 08 Sep 2022 | 4,000 | 15,300,468 | - | 2.7 | 10,680 | Common Stock |
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.58 per share. | 02 Sep 2022 | 6,000 | 15,296,468 | - | 2.6 | 15,480 | Common Stock |
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.55 per share. | 02 Sep 2022 | 4,000 | 15,290,468 | - | 2.6 | 10,200 | Common Stock |
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.19 per share. | 10 Jun 2022 | 1,520 | 15,286,468 | - | 2.2 | 3,326 | Common Stock |
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.24 per share. | 07 Jun 2022 | 2,000 | 15,284,948 | - | 2.2 | 4,490 | Common Stock |
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.31 per share. | 07 Jun 2022 | 1,000 | 15,282,948 | - | 2.3 | 2,310 | Common Stock |
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2021 | 800,000 | 800,000 | - | - | Stock Option (Right to Buy) | |
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.94 per share. | 31 Aug 2021 | 5,830 | 15,281,948 | - | 3.9 | 22,970 | Common Stock |
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.76 per share. | 27 Aug 2021 | 8,000 | 15,270,118 | - | 3.8 | 30,100 | Common Stock |
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | 22 Jul 2021 | 6,316,691 | 0 | - | - | Series A Redeemable Preferred Stock | ||
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | 22 Jul 2021 | 6,316,691 | 10,602,405 | - | 0 | Common Stock | ||
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | 22 Jul 2021 | 2,954,285 | 0 | - | - | Series B Redeemable Preferred Stock | ||
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | 22 Jul 2021 | 2,954,285 | 13,556,690 | - | 0 | Common Stock | ||
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | 22 Jul 2021 | 1,071,428 | 14,628,118 | - | 0 | Common Stock | ||
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | 22 Jul 2021 | 1,071,428 | 0 | - | - | Series C Redeemable Preferred Stock | ||
| HCW Biologics Inc | Hing C. Wong | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 22 Jul 2021 | 627,500 | 15,255,618 | - | 8 | 5,020,000 | Common Stock |